Evidence map›Paper›PMID 38003256›Full record

ArticleInternational journal of molecular sciences2023

Ischemia-Reperfusion Increases TRPM7 Expression in Mouse Retinas.

Natalia Martínez-Gil, Oksana Kutsyr, Laura Fernández-Sánchez, Xavier Sánchez-Sáez, Henar Albertos-Arranz, Carla Sánchez-Castillo, Lorena Vidal-Gil, Nicolás Cuenca, Pedro Lax, Victoria Maneu

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Interplay Between Ocular Ischemia and Glaucoma: An Update.International journal of molecular sciences · 2024
    Review
  6. The Variety of Mechanosensitive Ion Channels in Retinal Neurons.International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Natalia Martínez-GilDepartamento de Fisiología, Genética y Microbiología, Universidad de Alicante, 03690 San Vicente del Raspeig, Alicante, Spain.ORCID 0000-0001-8882-5602
Oksana KutsyrDepartamento de Óptica, Farmacología y Anatomía, Universidad de Alicante, 03690 San Vicente del Raspeig, Alicante, Spain.ORCID 0000-0002-1173-6916
Laura Fernández-SánchezDepartamento de Óptica, Farmacología y Anatomía, Universidad de Alicante, 03690 San Vicente del Raspeig, Alicante, Spain.ORCID 0000-0002-3629-0156
Xavier Sánchez-SáezDepartamento de Fisiología, Genética y Microbiología, Universidad de Alicante, 03690 San Vicente del Raspeig, Alicante, Spain.ORCID 0000-0001-5128-0979
Henar Albertos-ArranzDepartamento de Fisiología, Genética y Microbiología, Universidad de Alicante, 03690 San Vicente del Raspeig, Alicante, Spain.ORCID 0000-0001-8656-9887
Carla Sánchez-CastilloDepartamento de Fisiología, Genética y Microbiología, Universidad de Alicante, 03690 San Vicente del Raspeig, Alicante, Spain.ORCID 0000-0002-3697-5825
Lorena Vidal-GilDepartamento de Fisiología, Genética y Microbiología, Universidad de Alicante, 03690 San Vicente del Raspeig, Alicante, Spain.
Nicolás CuencaDepartamento de Fisiología, Genética y Microbiología, Universidad de Alicante, 03690 San Vicente del Raspeig, Alicante, Spain.ORCID 0000-0002-6767-5710
Pedro LaxDepartamento de Fisiología, Genética y Microbiología, Universidad de Alicante, 03690 San Vicente del Raspeig, Alicante, Spain.ORCID 0000-0001-6931-1008
Victoria ManeuDepartamento de Óptica, Farmacología y Anatomía, Universidad de Alicante, 03690 San Vicente del Raspeig, Alicante, Spain.ORCID 0000-0002-5265-1361
University of Alicante · ES

Funding

Generalitat Valenciana-FEDER IDIFEDER/2017/064Generalitat Valenciana-FEDER PROMETEO/2021/024Ministerio de Ciencia e Innovación, Spain FEDER-PID 2019-106230RB-I00Ministerio de Universidades, Spain FPU16/04114, FPU-18/02964Retina Asturias 2019/00286/001
6 · The paper itself

Abstract

Ischemia is the main cause of cell death in retinal diseases such as vascular occlusions, diabetic retinopathy, glaucoma, or retinopathy of prematurity. Although excitotoxicity is considered the primary mechanism of cell death during an ischemic event, antagonists of glutamatergic receptors have been unsuccessful in clinical trials with patients suffering ischemia or stroke. Our main purpose was to analyze if the transient receptor potential channel 7 (TRPM7) could contribute to retinal dysfunction in retinal pathologies associated with ischemia. By using an experimental model of acute retinal ischemia, we analyzed the changes in retinal function by electroretinography and the changes in retinal morphology by optical coherence tomography (OCT) and OCT-angiography (OCTA). Immunohistochemistry was performed to assess the pattern of TRPM7 and its expression level in the retina. Our results show that ischemia elicited a decrease in retinal responsiveness to light stimuli along with reactive gliosis and a significant increase in the expression of TRPM7 in Müller cells. TRPM7 could emerge as a new drug target to be explored in retinal pathologies associated with ischemia.

Indexed as

Retinal DiseasesTRPM Cation ChannelsAnimalsHumansInfant, NewbornIschemiaMiceProtein Serine-Threonine KinasesReperfusionRetinaRetinal VesselsProtein Serine-Threonine KinasesTRPM7 protein, humanTrpm7 protein, mouseTRPM Cation Channelsischemiareperfusionretina degenerationTRPTRPM7

Identifiers

PMID38003256
PMCPMC10671235
OpenAlexW4388495807

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.